Showing results (261-270 of 266) with videos related to
Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 266 results.
Science (New York, N.Y.)|January 29, 2026
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapyJunedh M Amrute, In-Hyuk Jung, Tracy Yamawaki, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 31, 2018
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection, John W Hirshfeld, Victor A Ferrari, et al.Hematological Oncology|February 19, 2020
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trialChristine Schmitz, Jan Rekowski, Stefan P Müller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2018
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III TrialUlrich Dührsen, Stefan Müller, Bernd Hertenstein, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 31, 2018
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Developed in Collaboration With Mended Hearts, John W Hirshfeld, Victor A Ferrari, et al.Annals of Hematology|January 6, 2019
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trialAndreas Hüttmann, Jan Rekowski, Stefan P Müller, et al.Pageof 27